A randomized controlled trial of pegylated-interferon alpha-2b plus ribavirin vs interferon

被引：1
|
作者：
Pol, S [1 ]
Perronne, C [1 ]
Carrat, F [1 ]
Banisadr, F [1 ]
Morand, P [1 ]
Lunel, F [1 ]
Rosenthal, E [1 ]
机构：
[1] ANRS HC02, Paris, France
来源：
JOURNAL OF HEPATOLOGY | 2003年 / 38卷
关键词：
D O I：
10.1016/S0168-8278(03)80508-1
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
92
引用
收藏
页码：32 / 32
页数：1
相关论文
共 50 条
  • [1] Treatment with pegylated-interferon alpha-2b (Peg-Interferon) plus ribavirin in relapsers to standard interferon plus ribavirin in chronic hepatitis C : Efficacy and safety results from a randomized multicentric french study.
    Portal, I
    Botta-Fridlund, D
    Bourliere, M
    Couzigou, P
    Barange, K
    Canva, V
    Larrey, D
    Rotily, M
    Halfon, P
    HEPATOLOGY, 2002, 36 (04) : 359A - 359A
  • [2] Efficacy and tolerability of pegylated interferon alpha-2a plus ribavirin versus pegylated interferon alpha-2b plus ribavirin, in treatment naive chronic hepatitis C patients
    Lee, S. Y.
    Lee, S.
    Ko, K. S.
    Kim, I. H.
    Kim, S. H.
    Kim, S. W.
    Lee, S. O.
    Lee, S. T.
    Kim, D. G.
    Choi, C. S.
    Cho, E. Y.
    Kim, H. C.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2009, 24 : A176 - A176
  • [3] A randomized, double-blind controlled trial of interferon alpha-2b and ribavirin vs. interferon alpha-2b and amantadine for treatment of chronic hepatitis C non-responder to interferon monotherapy
    Younossi, ZM
    Mullen, KD
    Zakko, W
    Hodnick, S
    Brand, E
    Barnes, DS
    Carey, WD
    McCullough, AC
    Easley, K
    Boparai, N
    Gramlich, T
    JOURNAL OF HEPATOLOGY, 2001, 34 (01) : 128 - 133
  • [4] Randomized placebo-controlled trial of interferon alpha-2b plus ribavirin with and without lactoferrin for chronic hepatitis C
    Ishibashi, Y
    Takeda, K
    Tsukidate, N
    Miyazaki, H
    Ohira, K
    Dosaka-Akita, H
    Nishimura, M
    HEPATOLOGY RESEARCH, 2005, 32 (04) : 218 - 223
  • [5] Peginterferon alpha-2b plus ribavirin vs interferon alpha-2b plus ribavirin for chronic hepatitis C in HIV-coinfected patients
    Crespo, M.
    Sauleda, S.
    Esteban, J. I.
    Juarez, A.
    Ribera, E.
    Andreu, A. L.
    Falco, V.
    Quer, J.
    Ocana, I.
    Ruiz, I.
    Buti, M.
    Pahissa, A.
    Esteban, R.
    Guardia, J.
    JOURNAL OF VIRAL HEPATITIS, 2007, 14 (04) : 228 - 238
  • [6] The safety and efficacy of Viramidine® plus pegylated interferon alpha-2b versus ribavirin plus pegylated interferon alpha-2b in therapy-naive patients infected with HCV:: Phase 3 results
    Murphy, B.
    JOURNAL OF CLINICAL VIROLOGY, 2006, 36 : S19 - S19
  • [7] The safety and efficacy of Viramidine® plus pegylated interferon alpha-2B versus ribavirin plus pegylated interferon alpha-2B in therapy-naive patients infected with HCV:: Phase 3 results
    Benhamou, Y.
    Pockros, P.
    Rodriguez-Torres, M.
    Gordon, S.
    Shiffman, M.
    Lurie, Y.
    Afdhal, N.
    Lamon, K.
    Kim, Y.
    Murphy, B.
    JOURNAL OF HEPATOLOGY, 2006, 44 : S273 - S273
  • [8] Pegylated interferon alpha-2b plus ribavirin for naive patients with HCV-related cirrhosis
    Floreani, Annarosa
    Baldo, Vincenzo
    Rizzotto, Erik Rosa
    Carderi, Isabella
    Baldovin, Tatjana
    Minola, Eliseo
    JOURNAL OF CLINICAL GASTROENTEROLOGY, 2008, 42 (06) : 734 - 737
  • [9] PEGYLATED INTERFERON ALFA-2A VS PEGYLATED INTERFERON ALFA-2B, PLUS RIBAVIRIN, FOR CHRONIC HEPATITIS C GENOTYPE 4 PATIENTS: A RANDOMIZED CONTROLLED TRIAL
    Kamal, Sanaa
    Ghoraba, Dalia
    Nabegh, Leila
    Nasser, Imad
    Motaoe, Mona
    Sayed, Mohamed E.
    Gohary, Iman
    HEPATOLOGY, 2009, 50 (04) : 1025A - 1026A
  • [10] Final results of ANRS HC02-ribavic:: A randomized controlled trial of pegylated-interferon α-2b plus ribavirin vs interferon α-2b plus ribavirin for naive HCV-HIV co-infected patients
    Pol, S
    Carrat, F
    Bani-Sadr, F
    Rosenthal, E
    Lunel, F
    Morand, P
    Salmon, D
    Pialoux, G
    Cacoub, R
    Perronne, C
    JOURNAL OF HEPATOLOGY, 2005, 42 : 10 - 11
12345